ArticleBMC nephrology2021

Rationale and design of the OPTIMIZE trial: OPen label multicenter randomized trial comparing standard IMmunosuppression with tacrolimus and mycophenolate mofetil with a low exposure tacrolimus regimen In combination with everolimus in de novo renal transplantation in Elderly patients.

S E de Boer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.